Increase in cancer screening may be result of ACA provision
the ONA take:
According to a new study published online in the journal Cancer, researchers from the American Cancer Society have found that colorectal cancer screening increased in individuals of lower socioeconomic status after 2008, potentially as a result of a provision in the Affordable Care Act that removed financial barriers to preventive services, including breast and colorectal cancer screening.
For the study, researchers analyzed data from the National Health Interview Survey to compare breast cancer and colorectal cancer screening prevalence among individuals with private and Medicare insurance by socioeconomic status before and after the Affordable Care Act was enacted.
Results showed that colorectal cancer screening increased from 57.3% to 61.2% between 2008 and 2013. The increase in screening prevalence was apparent in least-educated, low-income, and Medicare-insured patients, but not among those in higher socioeconomic groups.
The researchers also found a significant increase in colorectal cancer screening among Medicare-insured and privately insured individuals across all socioeconomic levels.
There was no increase in breast cancer screening between 2008 and 2013, possibly due to fewer barriers because of lower cost, women's health initiatives, and the already higher prevalence of breast cancer screening prevalence compared with colorectal cancer screening.
Affordable Care Act has removed financial barriers to preventive services, including breast and colorectal cancer screening.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|